Joseph W.  Dziedzic net worth and biography

Joseph Dziedzic Biography and Net Worth

CEO of Integer
Mr. Dziedzic has served as President and Chief Executive Officer of the Company since March 2017. Prior to being appointed as the President and Chief Executive Officer of the Company, Mr. Dziedzic served as Chair of the Audit Committee and a member of the Compensation and Organization Committee. From 2009 to 2016, Mr. Dziedzic was the Executive Vice President and Chief Financial Officer of The Brink’s Company, a global leader in security-related services for banks, retailers and a variety of other commercial and governmental customers. Prior to joining The Brink’s Company in 2009, he had a 20-year career with General Electric, including leadership roles in six different businesses, including General Electric Medical Systems.

What is Joseph W. Dziedzic's net worth?

The estimated net worth of Joseph W. Dziedzic is at least $13.41 million as of December 16th, 2022. Mr. Dziedzic owns 122,378 shares of Integer stock worth more than $13,411,405 as of April 27th. This net worth evaluation does not reflect any other assets that Mr. Dziedzic may own. Additionally, Mr. Dziedzic receives a salary of $3,240,000.00 as CEO at Integer. Learn More about Joseph W. Dziedzic's net worth.

How old is Joseph W. Dziedzic?

Mr. Dziedzic is currently 56 years old. There are 9 older executives and no younger executives at Integer. Learn More on Joseph W. Dziedzic's age.

What is Joseph W. Dziedzic's salary?

As the CEO of Integer Holdings Co., Mr. Dziedzic earns $3,240,000.00 per year. Learn More on Joseph W. Dziedzic's salary.

How do I contact Joseph W. Dziedzic?

The corporate mailing address for Mr. Dziedzic and other Integer executives is 5830 Granite Parkway Suite 1150, Plano TX, 75024. Integer can also be reached via phone at (214) 618-5243 and via email at [email protected]. Learn More on Joseph W. Dziedzic's contact information.

Has Joseph W. Dziedzic been buying or selling shares of Integer?

Joseph W. Dziedzic has not been actively trading shares of Integer in the last ninety days. Most recently, on Friday, December 16th, Joseph W. Dziedzic bought 4,000 shares of Integer stock. The stock was acquired at an average cost of $61.95 per share, with a total value of $247,800.00. Following the completion of the transaction, the chief executive officer now directly owns 122,378 shares of the company's stock, valued at $7,581,317.10. Learn More on Joseph W. Dziedzic's trading history.

Who are Integer's active insiders?

Integer's insider roster includes Pamela Bailey (Director), Anthony Borowicz (SVP), Joseph Dziedzic (CEO), Joseph Flanagan (EVP), Jean Hobby (Director), Carter Houghton (Insider), Bill Sanford (Director), and Donald Spence (Director). Learn More on Integer's active insiders.

Are insiders buying or selling shares of Integer?

In the last twelve months, insiders at the medical equipment provider sold shares 2 times. They sold a total of 10,125 shares worth more than $839,036.25. The most recent insider tranaction occured on September, 11th when Director Donald J Spence sold 6,500 shares worth more than $535,080.00. Insiders at Integer own 2.0% of the company. Learn More about insider trades at Integer.

Information on this page was last updated on 9/11/2023.

Joseph W. Dziedzic Insider Trading History at Integer

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/16/2022Buy4,000$61.95$247,800.00122,378View SEC Filing Icon  
11/5/2020Buy5,000$58.12$290,600.0079,793View SEC Filing Icon  
1/3/2018Sell3,182$44.89$142,839.9821,351View SEC Filing Icon  
See Full Table

Joseph W. Dziedzic Buying and Selling Activity at Integer

This chart shows Joseph W Dziedzic's buying and selling at Integer by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Integer Company Overview

Integer logo
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.
Read More

Today's Range

Now: $109.59
Low: $107.11
High: $111.25

50 Day Range

MA: $113.11
Low: $98.56
High: $123.34

2 Week Range

Now: $109.59
Low: $69.40
High: $123.99

Volume

604,251 shs

Average Volume

342,875 shs

Market Capitalization

$3.67 billion

P/E Ratio

40.74

Dividend Yield

N/A

Beta

1.1